Amarin Corp Plc (AMRN)

[sts66]

Patent law obviousness and FDA approved drug indication are completely different animals - R-IT patents were granted under the assumption that they were accurate descriptions for method of use, but FDA requires proof the drug actually does what the patent claims. As far as JELIS, as long as I've known about AMRN I've wondered why JELIS didn't make R-IT obvious to try, regardless of whether anyone else wanted to spend the money to find out if and how EPA worked in treating CVD.